0 XP   0   0   0

Pardes Biosciences Inc










Financial Health of Pardes Biosciences Inc




Comparing to competitors in the Biotechnology industry




  Industry Rankings  


Pardes Biosciences Inc
Buy, Hold or Sell?

Should you buy, hold or sell Pardes Biosciences Inc?

I guess you are interested in Pardes Biosciences Inc. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

Let's analyse Pardes Biosciences Inc

Let's start. I'm going to help you getting a better view of Pardes Biosciences Inc. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

  1. Company's Financial Health
    A deep dive into the books. How are the numbers doing? Is Pardes Biosciences Inc even making a profit? Is the company skyrocketing? Or is it sinking like the Titanic. The trend is your friend.
  2. Market Valuation
    Finally, you now have an insight of how Pardes Biosciences Inc is doing in the market. If the company is worth buying. The latest step is to find out how other investors value Pardes Biosciences Inc. The closing price on 2022-12-02 was $1.09 per share. Is the company over- or underpriced?
  3. Key Performance Indicators
    A total overlook on how the company is doing. Based on the (trends in) the key performance indicators.
Pardes Biosciences Inc Daily Candlestick Chart

Summary

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
Using its assets, the company is very inefficient in making profit.
Using its investors money, the company is very inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
Liquidity Details
 Compared to previous yearCompared to industry
The company is very able to pay all its short-term debts.
The company is very able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is able to pay all its debts by selling its assets.
The company is very able to pay all its debts with equity.

1.1. Profitability of Pardes Biosciences Inc.

1.1. Profitability
1.1.1. Net Profit Margin

Measures how much net profit Pardes Biosciences Inc earns for each $1 of revenue.

  • Above 10% is considered healthy but always compare Pardes Biosciences Inc to the Biotechnology industry mean.
  • A Net Profit Margin of 0.0% means that $0.00 for each $1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Pardes Biosciences Inc:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.0%
TTM-5Y-0.0%
5Y-10Y-0.0%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ--223.6%+223.6%
TTM--281.7%+281.7%
5Y--450.1%+450.1%
10Y--541.0%+541.0%
1.1.2. Return on Assets

Shows how efficient Pardes Biosciences Inc is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Pardes Biosciences Inc to the Biotechnology industry mean.
  • -11.8% Return on Assets means that Pardes Biosciences Inc generated $-0.12 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Pardes Biosciences Inc:

  • The MRQ is -11.8%. Using its assets, the company is very inefficient in making profit. -2
  • The TTM is -16.4%. Using its assets, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-11.8%TTM-16.4%+4.6%
TTM-16.4%5Y-16.4%0.0%
5Y-16.4%10Y-16.4%0.0%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-11.8%-9.9%-1.9%
TTM-16.4%-8.9%-7.5%
5Y-16.4%-11.7%-4.7%
10Y-16.4%-12.7%-3.7%
1.1.3. Return on Equity

Shows how efficient Pardes Biosciences Inc is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Pardes Biosciences Inc to the Biotechnology industry mean.
  • -12.4% Return on Equity means Pardes Biosciences Inc generated $-0.12 for each $1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Pardes Biosciences Inc:

  • The MRQ is -12.4%. Using its investors money, the company is very inefficient in making profit. -2
  • The TTM is -6.6%. Using its investors money, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-12.4%TTM-6.6%-5.8%
TTM-6.6%5Y-6.6%0.0%
5Y-6.6%10Y-6.6%0.0%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-12.4%-12.0%-0.4%
TTM-6.6%-11.5%+4.9%
5Y-6.6%-14.2%+7.6%
10Y-6.6%-15.2%+8.6%

1.2. Operating Efficiency of Pardes Biosciences Inc.

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient Pardes Biosciences Inc is operating .

  • Measures how much profit Pardes Biosciences Inc makes for each $1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Pardes Biosciences Inc to the Biotechnology industry mean.
  • An Operating Margin of 0.0% means the company generated $0.00  for each $1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Pardes Biosciences Inc:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.0%
TTM-5Y-0.0%
5Y-10Y-0.0%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ--207.3%+207.3%
TTM--271.0%+271.0%
5Y--454.0%+454.0%
10Y--537.1%+537.1%
1.2.2. Operating Ratio

Measures how efficient Pardes Biosciences Inc is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Biotechnology industry mean).
  • An Operation Ratio of 0.00 means that the operating costs are $0.00 for each $1 in net sales.

Let's take a look of the Operating Ratio trends of Pardes Biosciences Inc:

  • The MRQ is 0.000. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.000
TTM-5Y-0.000
5Y-10Y-0.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-2.871-2.871
TTM-3.504-3.504
5Y-5.132-5.132
10Y-6.371-6.371

1.3. Liquidity of Pardes Biosciences Inc.

1.3. Liquidity
1.3.1. Current Ratio

Measures if Pardes Biosciences Inc is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Biotechnology industry mean).
  • A Current Ratio of 20.84 means the company has $20.84 in assets for each $1 in short-term debts.

Let's take a look of the Current Ratio trends of Pardes Biosciences Inc:

  • The MRQ is 20.841. The company is very able to pay all its short-term debts. +2
  • The TTM is 21.298. The company is very able to pay all its short-term debts. +2
Trends
Current periodCompared to+/- 
MRQ20.841TTM21.298-0.457
TTM21.2985Y21.2980.000
5Y21.29810Y21.2980.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ20.8415.117+15.724
TTM21.2985.755+15.543
5Y21.2986.511+14.787
10Y21.2986.222+15.076
1.3.2. Quick Ratio

Measures if Pardes Biosciences Inc is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Pardes Biosciences Inc to the Biotechnology industry mean.
  • A Quick Ratio of 20.37 means the company can pay off $20.37 for each $1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Pardes Biosciences Inc:

  • The MRQ is 20.372. The company is very able to pay all its short-term debts with the most liquid assets. +2
  • The TTM is 19.658. The company is very able to pay all its short-term debts with the most liquid assets. +2
Trends
Current periodCompared to+/- 
MRQ20.372TTM19.658+0.714
TTM19.6585Y19.6580.000
5Y19.65810Y19.6580.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ20.3724.284+16.088
TTM19.6584.664+14.994
5Y19.6585.218+14.440
10Y19.6585.182+14.476

1.4. Solvency of Pardes Biosciences Inc.

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of Pardes Biosciences Inc assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Pardes Biosciences Inc to Biotechnology industry mean.
  • A Debt to Asset Ratio of 0.05 means that Pardes Biosciences Inc assets are financed with 4.8% credit (debt) and the remaining percentage (100% - 4.8%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Pardes Biosciences Inc:

  • The MRQ is 0.048. The company is very able to pay all its debts by selling its assets. +2
  • The TTM is 0.598. The company is able to pay all its debts by selling its assets. +1
Trends
Current periodCompared to+/- 
MRQ0.048TTM0.598-0.550
TTM0.5985Y0.5980.000
5Y0.59810Y0.5980.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.0480.278-0.230
TTM0.5980.277+0.321
5Y0.5980.367+0.231
10Y0.5980.403+0.195
1.4.2. Debt to Equity Ratio

Measures if Pardes Biosciences Inc is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Pardes Biosciences Inc to the Biotechnology industry mean.
  • A Debt to Equity ratio of 5.0% means that company has $0.05 debt for each $1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Pardes Biosciences Inc:

  • The MRQ is 0.050. The company is very able to pay all its debts with equity. +2
  • The TTM is 0.030. The company is very able to pay all its debts with equity. +2
Trends
Current periodCompared to+/- 
MRQ0.050TTM0.030+0.020
TTM0.0305Y0.0300.000
5Y0.03010Y0.0300.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.0500.315-0.265
TTM0.0300.317-0.287
5Y0.0300.403-0.373
10Y0.0300.462-0.432

2. Market Valuation of Pardes Biosciences Inc

2. Earnings Per Share
2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every $1 in earnings Pardes Biosciences Inc generates.

  • Above 15 is considered overpriced but always compare Pardes Biosciences Inc to the Biotechnology industry mean.
  • A PE ratio of -6.92 means the investor is paying $-6.92 for every $1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Pardes Biosciences Inc:

  • The EOD is -2.458. Company is losing money. -2
  • The MRQ is -6.923. Company is losing money. -2
  • The TTM is -38.250. Company is losing money. -2
Trends
Current periodCompared to+/- 
EOD-2.458MRQ-6.923+4.465
MRQ-6.923TTM-38.250+31.327
TTM-38.2505Y-38.2500.000
5Y-38.25010Y-38.2500.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-2.458-8.986+6.528
MRQ-6.923-9.792+2.869
TTM-38.250-16.243-22.007
5Y-38.250-16.665-21.585
10Y-38.250-14.732-23.518
2.2. Price Earnings to Growth Ratio

Measures the predicted future growth of Pardes Biosciences Inc.

  • Lower is better.
  • A PEG ratio of 1 means the market price of the stock and the expected future earnings are on par.

Let's take a look of the Price Earnings to Growth Ratio trends of Pardes Biosciences Inc:

  • The MRQ is 30.874. Seems overpriced? -1
  • The TTM is 151.461. Seems overpriced? -1
Trends
Current periodCompared to+/- 
MRQ30.874TTM151.461-120.587
TTM151.4615Y151.4610.000
5Y151.46110Y151.4610.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ30.874-0.032+30.906
TTM151.4610.004+151.457
5Y151.4610.006+151.455
10Y151.4610.003+151.458

2. Book Value per Share
2.3. Price to Book Ratio

Measures if the stock price of Pardes Biosciences Inc is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Biotechnology industry mean).
  • A PB ratio of 0.86 means the investor is paying $0.86 for each $1 in book value.

Let's take a look of the Price to Book Ratio trends of Pardes Biosciences Inc:

  • The EOD is 0.305. Very good. +2
  • The MRQ is 0.859. Very good. +2
  • The TTM is -2.619. Bad. Book ratio is negative. -2
Trends
Current periodCompared to+/- 
EOD0.305MRQ0.859-0.554
MRQ0.859TTM-2.619+3.478
TTM-2.6195Y-2.6190.000
5Y-2.61910Y-2.6190.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD0.3051.835-1.530
MRQ0.8592.006-1.147
TTM-2.6192.774-5.393
5Y-2.6192.713-5.332
10Y-2.6192.402-5.021
2. Total Gains per Share

3. Holders & Insider Transactions

Let's take a look at which institutions, funds and insiders are holding shares of Pardes Biosciences Inc.

3.1. Institutions holding Pardes Biosciences Inc

Institutions are holding 76.437% of the shares of Pardes Biosciences Inc.

DateNameTotal SharesTotal AssetsCurrent SharesChange%
2022-06-30Foresite Capital Management V, LLC15.08420.1619940051500
2022-06-30RA Capital Management, LLC9.90850.5055617503800
2022-06-30VK Services LLC9.87112.8157615176661517660
2022-06-30Foresite Capital Opportunity Management V, LLC8.387740.4436522730700
2022-06-30Goldman Sachs Group Inc6.86110.00342759142163503102.4187
2022-06-30T. Rowe Price Associates, Inc.2.0640.00051286324-530235-29.189
2022-06-30Junked Platinum Investment Management Ltd1.95110.14121215967-34711-2.7754
2022-06-30Vanguard Group Inc1.76830.0001110203411606011.7711
2022-06-30ARENA CAPITAL ADVISORS, LLC1.3660.6685128100
2022-06-30Partner Fund Management LP1.28560.0938801204708479.7003
2022-06-30Geode Capital Management, LLC0.78770.0002490892267904120.1428
2022-06-30Dafna Capital Management LLC0.72380.3775451105299487.1109
2022-06-30Adage Capital Partners Gp LLC0.72210.003245000000
2022-06-30Harvard Management Co Inc0.64180.142240000000
2022-06-30Chescapmanager LLC0.58040.2622361716-224310-38.2765
2022-06-30State Street Corporation0.53960.0001336308253888308.0417
2022-06-30Sio Capital Management, LLC0.50640.36431556400
2022-06-30Point72 Asset Management, L.P.0.42750.0035266400-165734-38.3525
2022-06-30Northern Trust Corp0.37380.0002232971182875365.0491
2022-06-30Alyeska Investment Group, L.P.0.3610.007922500000
Total 64.211565.986340017306+8281801+20.7%

3.2. Funds holding Pardes Biosciences Inc

DateNameTotal SharesTotal AssetsCurrent SharesChange%
2022-09-30iShares Russell 2000 ETF1.1160.00276955244840.0696
2022-09-30Vanguard Total Stock Mkt Idx Inv0.98780.000161560000
2022-09-30Vanguard Instl Ttl Stck Mkt Idx Tr0.98780.000161560000
2022-09-30Vanguard Extended Market Index Investor0.56230.000835040900
2022-09-30iShares Russell 2000 Value ETF0.54010.0057336567-597-0.1771
2022-09-30T. Rowe Price Health Sciences0.44140.0037275099-192024-41.1078
2022-09-30T. Rowe Price New Horizons0.40110.0022249987-174868-41.1595
2022-06-30MEDICAL BioHealth EUR Acc0.39390.114624548200
2022-07-31Fidelity® Small Cap Index0.33660.003120979800
2022-08-31APO Medical Opportunities R0.24450.06061523517000085.002
2022-08-31Fidelity® Extended Market Index0.22410.0016139632-896-0.6376
2022-09-30State St Russell Sm/Mid Cp® Indx NL Cl C0.17750.000711061800
2022-09-30NT R2000 Value Index Fund - NL0.17610.0061097282242525.6864
2022-09-30Franklin Biotechnology Discv A(acc)USD0.17040.012610620000
2022-09-30State St Russell Sm Cap® Indx NL Cl C0.16790.002310463643364.323
2022-09-30NT R2000 Index Fund - NL0.16070.0031001762047425.6882
2022-09-30Vanguard Russell 2000 ETF0.12950.0028806991536723.5214
2022-09-30Schwab Small Cap Index0.12150.0029757041345421.6129
2022-08-31Allspring Factor Enhanced Small Cap Eq0.12120.210475519755190
2022-09-30NT R2000 Index Fund - DC - NL - 20.11980.003746481577626.7971
Total 7.58020.43894723977-130550-2.8%

4. Summary

4.1. Key Performance Indicators

The key performance indicators of Pardes Biosciences Inc compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share---0.3810.893-143%--0.893-143%0.893-143%
Book Value Growth---0.1070.317-134%--0.317-134%0.317-134%
Book Value Per Share--3.5722.802+27%--2.802+27%2.802+27%
Book Value Per Share Growth---0.1070.317-134%--0.317-134%0.317-134%
Current Ratio--20.84121.298-2%--21.298-2%21.298-2%
Debt To Asset Ratio--0.0480.598-92%--0.598-92%0.598-92%
Debt To Equity Ratio--0.0500.030+69%--0.030+69%0.030+69%
Dividend Per Share----0%---0%-0%
Eps---0.443-0.301-32%---0.301-32%-0.301-32%
Eps Growth---0.224-0.251+12%---0.251+12%-0.251+12%
Gross Profit Margin--1.0001.0000%--1.0000%1.0000%
Net Profit Margin----0%---0%-0%
Operating Margin----0%---0%-0%
Operating Ratio----0%---0%-0%
Pb Ratio0.305-182%0.859-2.619+405%---2.619+405%-2.619+405%
Pe Ratio-2.458+64%-6.923-38.250+453%---38.250+453%-38.250+453%
Peg Ratio--30.874151.461-80%--151.461-80%151.461-80%
Price Per Share1.090-182%3.0709.153-66%--9.153-66%9.153-66%
Price To Total Gains Ratio-2.860+64%-8.056-11.140+38%---11.140+38%-11.140+38%
Profit Growth---22.423-25.089+12%---25.089+12%-25.089+12%
Quick Ratio--20.37219.658+4%--19.658+4%19.658+4%
Return On Assets---0.118-0.164+39%---0.164+39%-0.164+39%
Return On Equity---0.124-0.066-47%---0.066-47%-0.066-47%
Total Gains Per Share---0.3810.893-143%--0.893-143%0.893-143%
Total Gains Per Share Growth---0.172-5.145+2892%---5.145+2892%-5.145+2892%
Usd Book Value--222632000.000174696250.000+27%--174696250.000+27%174696250.000+27%
Usd Book Value Change Per Share---0.3810.893-143%--0.893-143%0.893-143%
Usd Book Value Per Share--3.5722.802+27%--2.802+27%2.802+27%
Usd Dividend Per Share----0%---0%-0%
Usd Eps---0.443-0.301-32%---0.301-32%-0.301-32%
Usd Price Per Share1.090-182%3.0709.153-66%--9.153-66%9.153-66%
Usd Profit---27637000.000-18734000.000-32%---18734000.000-32%-18734000.000-32%
Usd Revenue----0%---0%-0%
Usd Total Gains Per Share---0.3810.893-143%--0.893-143%0.893-143%
 EOD+3 -2MRQTTM+12 -15YOY+0 -05Y+12 -1510Y+12 -15

4.2. Fundamental Score

Let's check the fundamental score of Pardes Biosciences Inc based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15-2.458
Price to Book Ratio (EOD)Between0-10.305
Net Profit Margin (MRQ)Greater than00.000
Operating Margin (MRQ)Greater than00.000
Quick Ratio (MRQ)Greater than120.372
Current Ratio (MRQ)Greater than120.841
Debt to Asset Ratio (MRQ)Less than10.048
Debt to Equity Ratio (MRQ)Less than10.050
Return on Equity (MRQ)Greater than0.15-0.124
Return on Assets (MRQ)Greater than0.05-0.118
Total5/10 (50.0%)

4.3. Technical Score

Let's check the technical score of Pardes Biosciences Inc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5046.019
Ma 20Greater thanMa 501.060
Ma 50Greater thanMa 1001.366
Ma 100Greater thanMa 2002.198
OpenGreater thanClose1.050
Total0/5 (0.0%)



Latest Balance Sheet

Balance Sheet of 2022-06-30. Currency in USD. All numbers in thousands.

Summary
Total Assets233,853
Total Liabilities11,221
Total Stockholder Equity222,632
 As reported
Total Liabilities 11,221
Total Stockholder Equity+ 222,632
Total Assets = 233,853

Assets

Total Assets233,853
Total Current Assets233,853
Long-term Assets233,853
Total Current Assets
Cash And Cash Equivalents 228,599
Other Current Assets 5,254
Total Current Assets  (as reported)233,853
Total Current Assets  (calculated)233,853
+/-0
Long-term Assets
Long-term Assets  (as reported)0
Long-term Assets  (calculated)0
+/-0

Liabilities & Shareholders' Equity

Total Current Liabilities11,221
Long-term Liabilities0
Total Stockholder Equity222,632
Total Current Liabilities
Accounts payable 1,684
Other Current Liabilities 9,537
Total Current Liabilities  (as reported)11,221
Total Current Liabilities  (calculated)11,221
+/-0
Long-term Liabilities
Long-term Liabilities  (as reported)0
Long-term Liabilities  (calculated)0
+/-0
Total Stockholder Equity
Common Stock6
Retained Earnings -100,601
Capital Surplus 323,227
Total Stockholder Equity (as reported)222,632
Total Stockholder Equity (calculated)222,632
+/-0
Other
Capital Stock6
Cash and Short Term Investments 228,599
Common Stock Shares Outstanding 57,686
Common Stock Total Equity6
Liabilities and Stockholders Equity 233,853
Net Debt -228,599
Net Invested Capital 222,632
Net Tangible Assets 222,632
Net Working Capital 222,632



Balance Sheet

Currency in USD. All numbers in thousands.

 Trend2022-06-302022-03-312021-12-312021-09-302021-06-302021-03-312020-12-31
> Total Assets 
0
0
0
28,581
275,259
255,144
233,853
233,853255,144275,25928,581000
   > Total Current Assets 
3,604
44,104
38,025
27,060
275,259
255,144
233,853
233,853255,144275,25927,06038,02544,1043,604
       Cash And Cash Equivalents 
0
0
0
26,384
268,678
247,919
228,599
228,599247,919268,67826,384000
       Other Current Assets 
0
0
0
0
6,581
7,225
5,254
5,2547,2256,5810000
   > Long-term Assets 
0
0
0
1,521
0
0
0
0001,521000
       Other Assets 
0
257
966
1,521
0
0
0
0001,5219662570
> Total Liabilities 
0
0
0
65,103
8,965
8,763
11,221
11,2218,7638,96565,103000
   > Total Current Liabilities 
16,610
2,682
5,214
5,971
8,965
8,763
11,221
11,2218,7638,9655,9715,2142,68216,610
       Accounts payable 
1,394
1,258
2,429
2,747
2,385
2,366
1,684
1,6842,3662,3852,7472,4291,2581,394
       Other Current Liabilities 
14,808
0
0
0
6,580
6,397
9,537
9,5376,3976,58000014,808
   > Long-term Liabilities 
0
0
0
59,132
0
0
0
00059,132000
       Deferred Long Term Liability 
0
257
966
1,521
0
0
0
0001,5219662570
> Total Stockholder Equity
0
0
0
-36,522
266,294
246,381
222,632
222,632246,381266,294-36,522000
   Common Stock
0
0
0
0
6
6
6
6660000
   Retained Earnings Total Equity-100,601-72,964-51,5240000
   Accumulated Other Comprehensive Income 0000000
   Capital Surplus 
0
0
0
0
317,812
319,339
323,227
323,227319,339317,8120000
   Treasury Stock0000000
   Other Stockholders Equity 
0
0
0
0
317,812
319,339
323,227
323,227319,339317,8120000



Balance Sheet

Currency in USD. All numbers in thousands.




Cash Flow

Currency in USD. All numbers in thousands.




Income Statement

Currency in USD. All numbers in thousands.


Latest Income Statement (annual, 2021-12-31)

Gross Profit (+$)
totalRevenue0
Cost of Revenue--
Gross Profit-0
 
Operating Income (+$)
Gross Profit-
Operating Expense-38,488
Operating Income-38,488-38,488
 
Operating Expense (+$)
Research Development28,152
Selling General Administrative10,336
Selling And Marketing Expenses-
Operating Expense38,48838,488
 
Net Interest Income (+$)
Interest Income-
Interest Expense-30
Net Interest Income-30-30
 
Pretax Income (+$)
Operating Income-38,488
Net Interest Income-30
Other Non-Operating Income Expenses-
Income Before Tax (EBT)38,488-38,488
EBIT - interestExpense = 38,458
-38,518
-38,488
Interest Expense30
Earnings Before Interest and Taxes (ebit)38,48838,518
Earnings Before Interest and Taxes (ebitda)38,488
 
After tax Income (+$)
Income Before Tax38,488
Tax Provision--
Net Income From Continuing Ops38,48838,488
Net Income-38,518
Net Income Applicable To Common Shares-38,518
 
Non-recurring Events
Discontinued Operations-
Extraordinary Items-
Effect of Accounting Charges-
Other Items-
Non Recurring-
Other Operating Expenses-
Total Other Income/Expenses Net-30
 

Comments

Join the conversation.

Leave a comment

Stay informed with my latest content.

Subscribe to my newsletter and receive an email as soon as I add content to PenkeTrading.com.


By clicking Register, you agree to the General Terms and Conditions.
Penke's Market Notifications
ZCL.CC
8 hours ago

I found you a Golden Cross on the daily chart of ZCL.CC.

ZCL.CC Daily Candlestick Chart
XPC.CC
8 hours ago

I found you a STOCH Bullish Reversal Divergence on the daily chart of XPC.CC.

XPC.CC Daily Candlestick Chart
XNC.CC
8 hours ago

I found you a STOCH Bullish Reversal Divergence on the daily chart of XNC.CC.

XNC.CC Daily Candlestick Chart
XMY.CC
8 hours ago

I found you a Three White Soldiers Candle Pattern on the daily chart of XMY.CC.

XMY.CC Daily Candlestick Chart
XFT.CC
8 hours ago

I found you a Rising Three Methods Candle Pattern on the daily chart of XFT.CC.

XFT.CC Daily Candlestick Chart
WING.CC
8 hours ago

I found you a STOCH Bearish Reversal Divergence on the daily chart of WING.CC.

WING.CC Daily Candlestick Chart
vUSDC.CC
8 hours ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of vUSDC.CC.

vUSDC.CC Daily Candlestick Chart
VOLLAR.CC
8 hours ago

I found you a Oversold RSI (Relative Strength Index) on the daily chart of VOLLAR.CC.

VOLLAR.CC Daily Candlestick Chart
UUU.CC
8 hours ago

I found you a MACD Bearish Reversal Divergence on the daily chart of UUU.CC.

UUU.CC Daily Candlestick Chart
UGAS.CC
8 hours ago

I found you a Bearish Three Line Strike Candle Pattern on the daily chart of UGAS.CC.

UGAS.CC Daily Candlestick Chart
UBQ.CC
8 hours ago

I found you a Death Cross on the daily chart of UBQ.CC.

UBQ.CC Daily Candlestick Chart
TRXBULL.CC
8 hours ago

I found you a STOCH Bearish Hidden Divergence on the daily chart of TRXBULL.CC.

TRXBULL.CC Daily Candlestick Chart
TH.CC
8 hours ago

I found you a STOCH Bearish Hidden Divergence on the daily chart of TH.CC.

TH.CC Daily Candlestick Chart
THC.CC
8 hours ago

I found you a STOCH Bullish Reversal Divergence on the daily chart of THC.CC.

THC.CC Daily Candlestick Chart
TEL.CC
8 hours ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of TEL.CC.

TEL.CC Daily Candlestick Chart
SWG.CC
8 hours ago

I found you a Death Cross on the daily chart of SWG.CC.

SWG.CC Daily Candlestick Chart
SNC.CC
8 hours ago

I found you a Death Cross on the daily chart of SNC.CC.

SNC.CC Daily Candlestick Chart
SHROOM.CC
8 hours ago

I found you a Morning Star Candle Pattern on the daily chart of SHROOM.CC.

SHROOM.CC Daily Candlestick Chart
SATT.CC
8 hours ago

I found you a STOCH Bullish Reversal Divergence on the daily chart of SATT.CC.

SATT.CC Daily Candlestick Chart
RYO.CC
8 hours ago

I found you a Oversold RSI (Relative Strength Index) on the daily chart of RYO.CC.

RYO.CC Daily Candlestick Chart
REAP.CC
8 hours ago

I found you a Bearish Three Line Strike Candle Pattern on the daily chart of REAP.CC.

REAP.CC Daily Candlestick Chart
RBN.CC
8 hours ago

I found you a Death Cross on the daily chart of RBN.CC.

RBN.CC Daily Candlestick Chart
RAK.CC
8 hours ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of RAK.CC.

RAK.CC Daily Candlestick Chart
PLAY.CC
8 hours ago

I found you a Death Cross on the daily chart of PLAY.CC.

PLAY.CC Daily Candlestick Chart